1. Home
  2. RCKT vs OTLY Comparison

RCKT vs OTLY Comparison

Compare RCKT & OTLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • OTLY
  • Stock Information
  • Founded
  • RCKT 1999
  • OTLY 1994
  • Country
  • RCKT United States
  • OTLY Sweden
  • Employees
  • RCKT N/A
  • OTLY N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • OTLY Packaged Foods
  • Sector
  • RCKT Health Care
  • OTLY Consumer Staples
  • Exchange
  • RCKT Nasdaq
  • OTLY Nasdaq
  • Market Cap
  • RCKT 328.6M
  • OTLY 303.5M
  • IPO Year
  • RCKT N/A
  • OTLY 2021
  • Fundamental
  • Price
  • RCKT $3.28
  • OTLY $17.29
  • Analyst Decision
  • RCKT Buy
  • OTLY Buy
  • Analyst Count
  • RCKT 13
  • OTLY 5
  • Target Price
  • RCKT $12.96
  • OTLY $19.25
  • AVG Volume (30 Days)
  • RCKT 5.9M
  • OTLY 178.2K
  • Earning Date
  • RCKT 11-06-2025
  • OTLY 11-06-2025
  • Dividend Yield
  • RCKT N/A
  • OTLY N/A
  • EPS Growth
  • RCKT N/A
  • OTLY N/A
  • EPS
  • RCKT N/A
  • OTLY N/A
  • Revenue
  • RCKT N/A
  • OTLY $828,200,000.00
  • Revenue This Year
  • RCKT N/A
  • OTLY $3.83
  • Revenue Next Year
  • RCKT $108.43
  • OTLY $4.51
  • P/E Ratio
  • RCKT N/A
  • OTLY N/A
  • Revenue Growth
  • RCKT N/A
  • OTLY 4.43
  • 52 Week Low
  • RCKT $2.19
  • OTLY $6.00
  • 52 Week High
  • RCKT $22.01
  • OTLY $20.80
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 51.09
  • OTLY 54.00
  • Support Level
  • RCKT $3.16
  • OTLY $17.75
  • Resistance Level
  • RCKT $3.40
  • OTLY $18.65
  • Average True Range (ATR)
  • RCKT 0.27
  • OTLY 0.81
  • MACD
  • RCKT -0.01
  • OTLY -0.22
  • Stochastic Oscillator
  • RCKT 32.79
  • OTLY 40.15

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About OTLY Oatly Group AB

Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, and Icecreams, among others. It caters to Sweden, Germany, the United Kingdom, Netherlands, North America, Finland, and Other markets. The company generates revenue from the EMEA, Americas, and Asia regions, with the majority of revenue generated from the EMEA region.

Share on Social Networks: